Literature DB >> 15076243

Rising prevalence of HIV-1 non-B subtypes in Belgium: 1983-2001.

Joke Snoeck1, Kristel Van Laethem, Philippe Hermans, Eric Van Wijngaerden, Inge Derdelinckx, Yoeri Schrooten, David A M C van de Vijver, Stéphanie De Wit, Nathan Clumeck, Anne-Mieke Vandamme.   

Abstract

This study documented the HIV-1 subtype distribution in 2 Belgian hospitals and determined predictive demographics for non-B subtypes. Overall, subtype B was the most prevalent subtype in this population, followed by subtypes A and C. Several recombinants were detected, circulating recombinants as well as new ones. We found a rise in non-B subtypes from 0% in 1983 to 57% in 2001. The Cochran-Armitage trend test (P < 0.001) as well as the correlation analysis (R = 0.71, P = 0.0006) was highly significant. Recombinants were also increasing in this patient population from 0% in 1983 to 10% in 2001, with good support from the statistical analyses (trend test P < 0.001; correlation analysis R = 0.67, P = 0.0016). Heterosexual route of infection, black African race, African origin of the virus, and year of diagnosis were predictors for infection with non-B subtypes in multivariate analysis. This analysis indicates that the prevalence of non-B subtypes and recombinants in this patient population is high and increasing. Gathering demographic and sequence information from newly diagnosed patients could be useful to further follow the spread of non-B subtypes in Belgium and Europe, but subtyping based on sequence information still remains the most reliable method.

Entities:  

Mesh:

Year:  2004        PMID: 15076243     DOI: 10.1097/00126334-200403010-00009

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  17 in total

1.  HIV diversity, molecular epidemiology, and the role of recombination.

Authors:  Gustavo H Kijak; Francine E McCutchan
Journal:  Curr Infect Dis Rep       Date:  2005-11       Impact factor: 3.725

2.  Intervening to reduce inequalities in infections in Europe.

Authors:  Jan C Semenza; Johan Giesecke
Journal:  Am J Public Health       Date:  2008-04-01       Impact factor: 9.308

3.  Use of sequence data generated in the Bayer Tru Gene genotyping assay to recognize and characterize non-subtype-b human immunodeficiency virus type 1 strains.

Authors:  Diane L Hirigoyen; Charles P Cartwright
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy.

Authors:  Philippa J Easterbrook; Mel Smith; Jane Mullen; Siobhan O'Shea; Ian Chrystie; Annemiek de Ruiter; Iain D Tatt; Anna Maria Geretti; Mark Zuckerman
Journal:  J Int AIDS Soc       Date:  2010-02-03       Impact factor: 5.396

5.  High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens.

Authors:  Florence Doualla-Bell; Ava Avalos; Bluma Brenner; Tendani Gaolathe; Madisa Mine; Simani Gaseitsiwe; Maureen Oliveira; Daniella Moisi; Ndwapi Ndwapi; Howard Moffat; Max Essex; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2006-10-02       Impact factor: 5.191

6.  Characteristics of patients recently infected with HIV-1 non-B subtypes in France: a nested study within the mandatory notification system for new HIV diagnoses.

Authors:  Denys Brand; Alain Moreau; Françoise Cazein; Florence Lot; Josiane Pillonel; Sylvie Brunet; Damien Thierry; Stéphane Le Vu; Jean-Christophe Plantier; Caroline Semaille; Francis Barin
Journal:  J Clin Microbiol       Date:  2014-09-17       Impact factor: 5.948

7.  Analysis of a local HIV-1 epidemic in portugal highlights established transmission of non-B and non-G subtypes.

Authors:  Alexandre Carvalho; Patrício Costa; Vera Triunfante; Fernando Branca; Fernando Rodrigues; Catarina L Santos; Margarida Correia-Neves; Margarida Saraiva; Henrique Lecour; António G Castro; Jorge Pedrosa; Nuno S Osório
Journal:  J Clin Microbiol       Date:  2015-02-18       Impact factor: 5.948

8.  Transmitted drug resistance in nonsubtype B HIV-1 infection.

Authors:  Philip A Chan; Rami Kantor
Journal:  HIV Ther       Date:  2009-09-01

9.  HIV-1 subtype F1 epidemiological networks among Italian heterosexual males are associated with introduction events from South America.

Authors:  Alessia Lai; Francesco R Simonetti; Gianguglielmo Zehender; Andrea De Luca; Valeria Micheli; Paola Meraviglia; Paola Corsi; Patrizia Bagnarelli; Paolo Almi; Alessia Zoncada; Stefania Paolucci; Angela Gonnelli; Grazia Colao; Danilo Tacconi; Marco Franzetti; Massimo Ciccozzi; Maurizio Zazzi; Claudia Balotta
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

10.  Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach.

Authors:  Dimitrios Paraskevis; Oliver Pybus; Gkikas Magiorkinis; Angelos Hatzakis; Annemarie Mj Wensing; David A van de Vijver; Jan Albert; Guiseppe Angarano; Birgitta Asjö; Claudia Balotta; Enzo Boeri; Ricardo Camacho; Marie-Laure Chaix; Suzie Coughlan; Dominique Costagliola; Andrea De Luca; Carmen de Mendoza; Inge Derdelinckx; Zehava Grossman; Osama Hamouda; Im Hoepelman; Andrzej Horban; Klaus Korn; Claudia Kücherer; Thomas Leitner; Clive Loveday; Eilidh Macrae; I Maljkovic-Berry; Laurence Meyer; Claus Nielsen; Eline Lm Op de Coul; Vidar Ormaasen; Luc Perrin; Elisabeth Puchhammer-Stöckl; Lidia Ruiz; Mika O Salminen; Jean-Claude Schmit; Rob Schuurman; Vincent Soriano; J Stanczak; Maja Stanojevic; Daniel Struck; Kristel Van Laethem; M Violin; Sabine Yerly; Maurizio Zazzi; Charles A Boucher; Anne-Mieke Vandamme
Journal:  Retrovirology       Date:  2009-05-20       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.